The Pharmaceutical (Drug) Research and Manufacturers of America is fighting in court to block the enforcement of a 2017 drug price transparency law. The law requires insurers and health plans to report drug prices to the state, among other information such as the reason for any increase. The case is titled Pharmaceutical Research and Manufacturers of America v. David (2:17-cv-02573-MCE-KJN).